EuropaBio

Tweet this page
<
2012
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
>
Registration as it was on 23 Jan 2017
How to read and use this data card.
Download this datacard

Overview

Lobbying Costs

250,000€

Financial year: Jan 2016 - Dec 2016

Lobbyists (Full time equivalent)

1 Fte (4)

Lobbyists with EP accreditation

8

High-level Commission meetings

48

Lobbying Costs over the years

  • Info

    EuropaBio

    EU Transparency Register

    1298286943-59 First registered on 08 Jan 2009

    Goals / Remit

    EuropaBio's mission is to create an innovative and dynamic biotechnology industry in Europe by communicating the benefits of biotech to all corners of society. The association works in all of the application fields of modern biotechnology, including healthcare, agriculture and food production, and industrial biotechnology.

    Members of EuropaBio are involved in research, development, testing, manufacturing and commercialisation of biotechnology products and processes. Our corporate members have a wide range of activities: human and animal health care, diagnostics, bio-informatics, chemicals, crop protection, agriculture, food and environmental products and services.



    EuropaBio also welcomes associate members such as international commercial, financial, asset management and other service-providing companies, regional biotechnology development organisations and scientific institutes. The common denominator among all our members is the use of biotechnology at any stage of research, development or manufacturing.



    We stand for free and open markets and the removal of barriers to competitiveness with other areas of the world.



    We are committed to open, informed communications with all stakeholders and the general public about the ethical, social and economic aspects of biotechnology and its applications.



    We champion the responsible use of biotechnology to ensure that its potential is fully used to the benefit of the environment and mankind.



    Sectors of particular interest include: agricultural, food, healthcare, environmental, industrial and innovation policy. As biotechnology is strongly based on innovation developed in start-up and small companies, policies related to the promotion of SMEs in the EU are a focus of attention. Biotechnology is a knowledge-based sector, and policies related to intellectual property rights are another important focus of attention.

    Main EU files targeted

    Bioeconomy Strategy and action plan
    GMO legislation and review of legislation
    Regulation on Advanced Therapy Medicinal Products
    Directive 98/44/EC on the legal protection of biotechnological inventions
    Clinical Trials Directive
    Horizon 2020

    Address

    Head Office
    avenue de l'Armée, 6
    Brussels 1040
    BELGIUM
  • People

    Total lobbyists declared

    4

    Employment timeLobbyists
    25%4

    Lobbyists (Full time equivalent)

    1

    Lobbyists with EP accreditation

    All Lobbyists with EP accreditation over time

    8 accreditations were / are live (in bold) for the selected state of 23 Jan 2017

    Name Start date End Date
    Mr Vlad OLTEANU 21 Feb 2024 20 Feb 2025
    Mr Adrien SAMSON 07 Feb 2024 06 Feb 2025
    Ms Claire SKENTELBERY 25 Jan 2024 24 Jan 2025
    Mr Jose DIOGO PERES 12 May 2023 10 May 2024
    Ms Anne Gaelle COLLOT 10 May 2023 09 May 2024
    Mr Vlad OLTEANU 03 Mar 2023 21 Feb 2024
    Mr Adrien SAMSON 16 Feb 2023 07 Feb 2024
    Ms Claire SKENTELBERY 09 Feb 2023 25 Jan 2024
    Ms Agnes BORG 14 Jan 2023 05 Apr 2023
    Mr Jamie Wilkinson 03 Jun 2022 14 Jan 2023
    Ms Claire SKENTELBERY 22 Feb 2022 09 Feb 2023
    Ms Agnes BORG 06 Jan 2022 06 Jan 2023
    Mr Bernard GRIMM 07 Oct 2021 16 Jan 2022
    Ms Claire SKENTELBERY 25 Nov 2020 25 Nov 2021
    Mr Bernard GRIMM 09 Oct 2020 07 Oct 2021
    Mr Darren KINSELLA 26 Feb 2020 26 Feb 2021
    Ms Agnes BORG 22 Feb 2020 20 Feb 2021
    Ms Violeta GEORGIEVA KOLEVA 10 Dec 2019 10 Dec 2020
    Mr Coen FREDERIKS 10 Oct 2019 26 Feb 2020
    Ms Joanna Dupont-Inglis 09 Oct 2019 15 Mar 2020
    Mr Bernard GRIMM 01 Oct 2019 01 Oct 2020
    Mr Beat SPATH 06 Sep 2019 05 Sep 2020
    Ms Agnes BORG 02 Mar 2019 22 Feb 2020
    Mr Mark MØLLER-NIELSEN 13 Oct 2018 12 Jan 2019
    Ms Joanna Dupont-Inglis 07 Sep 2018 01 Oct 2019
    Mr Bernard GRIMM 07 Sep 2018 01 Oct 2019
    Mr Pedro NARRO SANCHEZ 03 Aug 2018 01 Sep 2019
    Ms Petra KOSTOLANIOVA 26 Jul 2018 01 Aug 2019
    Mr Beat SPATH 11 Jul 2018 11 Jul 2019
    Mr John Brennan 02 Jun 2018 05 Sep 2018
    Mr Davide MARCHI 20 Jan 2018 21 Mar 2018
    Mr Darren KINSELLA 15 Jan 2018 13 Jan 2019
    Ms Agnes BORG 09 Jan 2018 09 Jan 2019
    Ms Violeta Georgieva 05 Oct 2017 29 Sep 2018
    Ms Joanna Dupont-Inglis 05 Oct 2017 07 Sep 2018
    Mr Pedro NARRO SANCHEZ 10 Aug 2017 03 Aug 2018
    Mr Beat SPATH 20 Jul 2017 11 Jul 2018
    Mr Ronald Jager 20 Jul 2017 09 Jan 2018
    Mr John Brennan 27 Jun 2017 02 Jun 2018
    Mr Alexander Gibbs 04 Apr 2017 21 Jul 2017
    Mr Davide MARCHI 23 Jan 2017 06 Jan 2018
    Ms Agnes BORG 05 Jan 2017 04 Jan 2018
    Ms Violeta Georgieva 10 Oct 2016 04 Oct 2017
    Ms Joanna Dupont-Inglis 10 Oct 2016 04 Oct 2017
    Mr Pedro NARRO SANCHEZ 13 Sep 2016 10 Aug 2017
    Mr Beat SPATH 22 Aug 2016 21 Jul 2017
    Ms Nathalie Moll 22 Aug 2016 01 Apr 2017
    Mr Ronald Jager 22 Aug 2016 21 Jul 2017
    Mr Alexander Gibbs 21 Apr 2016 04 Apr 2017
    Ms Agnes BORG 03 Feb 2016 05 Jan 2017
    Ms Violeta Georgieva 14 Oct 2015 11 Oct 2016
    Ms Joanna Dupont-Inglis 14 Oct 2015 11 Oct 2016
    Mr Riccardo Mezzasalma 25 Sep 2015 14 Sep 2016
    Mr Beat SPATH 06 Aug 2015 03 Aug 2016
    Ms Nathalie Moll 06 Aug 2015 03 Aug 2016
    Mr Pedro NARRO SANCHEZ 06 Aug 2015 03 Aug 2016
    Ms Miriam Gargesi 01 Aug 2015 20 Jul 2016
    Ms Joanna Dupont-Inglis 23 Oct 2014 14 Oct 2015
    Ms Nathalie Moll 07 Aug 2014 05 Aug 2015
    Ms Violeta Georgieva 25 Oct 2014 14 Oct 2015
    Mrs Joanna Dupont-Inglis 23 Oct 2014 27 Jan 2015
    Mr Antoine Peeters 21 Oct 2014 02 Sep 2015
    Mr Riccardo Mezzasalma 23 Sep 2014 18 Sep 2015
    Mrs Nilsy Desaint 23 Sep 2014 07 Jan 2015
    Mr Beat SPATH 07 Aug 2014 05 Aug 2015
    Mrs Nathalie Moll 07 Aug 2014 27 Jan 2015
    Mr Beat SPATH 17 Apr 2013 16 Apr 2014
    Mr Beat SPATH 24 Apr 2012 02 Apr 2013
    Mrs Pauline BASTIDON 17 Jan 2012 21 Oct 2012

    Complementary Information

    9 people on the basis of staff time ( prorata in percentage)
    on 20% and 5% of their time: 105% = 1FTE

    Person in charge of EU relations

    Ms Nathalie Moll (Secretary General)

    Person with legal responsibility

    Ms Nathalie Moll (Secretary General)

  • Categories

    Category

    II - In-house lobbyists and trade/business/professional associations

    Subcategory

    Trade and business associations

  • Networking

    Affiliation

    Croplife International
    http://www.europabio.org/members

    Member organisations

    None declared

  • Financial Data

    Closed financial year

    Jan 2016 - Dec 2016

    Lobbying costs for closed financial year

    250,000€

    Other financial info

    INCOME FROM MEMBERSHIP FEES

  • EU Structures

    Groups (European Commission)

    None

    ACC

    None

    Groups (European Parliament)

    None

    Communication activities

    None

    Other activities

    Main policy areas of interest in the last year:

    Healthcare:

    • All EU policy tracks related to pharmaceuticals, their regulation and access, and to the development of an innovative EU healthcare biotech sector.

    Agriculture:

    • All EU policy tracks related to regulation affecting the use of modern biotechnology in agriculture, environment and food

    Industrial biotechnology:

    • All EU policy tracks related to the development of the bio-based economy (e.g. agricultural policy, research and innovation, industry and competitiveness, environment, climate change, trade, energy and transport, etc.).

    Horizontal issues:

    • SME policy
    • All policy developments related to intellectual property rights

  • Meetings

    Meetings

    48 meetings found. Download meetings

    The list below only covers meetings held since November 2014 with commissioners, their cabinet members or directors-general at the European Commission; other lobby meetings with lower-level staff may have taken place, but the European Commission doesn't proactively publish information about these meetings. For more information about which commissioner is responsible for which portfolio, check out this link: https://commissioners.ec.europa.eu/index_en All information below comes from European Commission web pages.

    • Date 22 Mar 2023 Location Brussels
      Subject Pharmaceutical package, biopharma
      Cabinet Cabinet of Executive Vice-President Margrethe Vestager
      Portfolio Europe Fit for Digital Age
      Attending
      • Pierre-Arnaud Proux (Cabinet member)
      • Stina Soewarta (Cabinet member)
    • Date 06 Mar 2023 Location Brussels
      Subject Pharma package
      Cabinet Cabinet of Executive Vice-President Valdis Dombrovskis
      Portfolio An Economy that Works for People
      Attending
      • Kevin Keary (Cabinet member)
      Other Lobbyists
    • Date 16 Feb 2023 Location Brussels
      Subject Presentation of a cross-sector Biomanufacturing Platform
      Cabinet Cabinet of Commissioner Elisa Ferreira
      Portfolio Cohesion and Reforms
      Attending
      • Simeona Manova (Cabinet member)
    • Date 25 Oct 2022 Location On line
      Subject Exchange of views on the upcoming reform of the pharmaceutical legislation
      Cabinet Cabinet of Commissioner Stella Kyriakides
      Portfolio Health
      Attending
      • Karolina Herbout-Borczak (Cabinet member)
      • Giorgios Rossides (Cabinet member)
    • Date 08 Apr 2021 Location online
      Subject Health Union
      Cabinet Cabinet of Vice-President Margaritis Schinas
      Portfolio Promoting the European Way of Life
      Attending
      • Catherine Sustek (Cabinet member)
      • Margaritis Schinas (Vice-President)
      Other Lobbyists
    • Date 04 Mar 2021 Location Brussels
      Subject New Europa Bio Director-General Dr. Claire Skentelbery, and new Chair of the Board Andrew Topen, wish to introduce themselves to Director-General Kerstin Jorna and hear DG GROW’s priorities, to see where EuropaBio could potentially assist.
      DG Internal Market, Industry, Entrepreneurship and SMEs
      Attending
      • Kerstin Jorna (Director-General)
    • Date 24 Sep 2020 Location Webex
      Subject Exchange of views on the upcoming pharmaceutical strategy
      Cabinet Cabinet of Commissioner Stella Kyriakides
      Portfolio Health
      Attending
      • Giorgios Rossides (Cabinet member)
    • Date 23 Jun 2020 Location Phone call
      Subject EuropaBio raises their concerns on the industrial strategy should inform the recovery; how industrial biotechnology and life science contribute to the Green Deal, competitiveness of industrial value chains and global level playing field
      DG Internal Market, Industry, Entrepreneurship and SMEs
      Attending
      • Kerstin Jorna (Director-General)
    • Date 27 Jan 2020 Location Brussels
      Subject Future of European Bio Industries
      Cabinet Cabinet of Commissioner Mariya Gabriel
      Portfolio Digital Economy and Society
      Attending
      • Dara Murphy (Cabinet member)
    • Date 27 Jan 2020 Location Brussels
      Subject Future of European Bio Industries
      Cabinet Cabinet of Commissioner Mariya Gabriel
      Portfolio Innovation and Youth
      Attending
      • Dara Murphy (Cabinet member)
    • Date 22 Jan 2020 Location Brussels
      Subject Business discussion
      Cabinet Cabinet of Commissioner Phil Hogan
      Portfolio Agriculture &amp; Rural Development
      Attending
      • Tom Tynan (Cabinet member)
    • Date 22 Jan 2020 Location Brussels
      Subject Business discussion
      Cabinet Cabinet of Commissioner Phil Hogan
      Attending
      • Tom Tynan (Cabinet member)
    • Date 09 Sep 2019 Location Brussels
      Subject discussion around bio pharmaceutical development and how to maintain the strength of this sector
      DG Health and Food Safety
      Attending
      • Anne Bucher (Director-General)
    • Date 04 Sep 2019 Location Brussels
      Subject Science based decision making. New biotechnologies
      Cabinet Cabinet of Commissioner Vytenis Andriukaitis
      Portfolio Health &amp; Food Safety
      Attending
      • Vytenis Andriukaitis (Commissioner)
      • Nathalie Chaze (Cabinet member)
    • Date 10 Jul 2019 Location BREY - Brussels
      Subject Courtesy meeting to introduce themselves and present their priorities
      DG Internal Market, Industry, Entrepreneurship and SMEs
      Attending
      • Timo Pesonen (Acting Director-General)
    • Date 23 Apr 2019 Location BRUSSELS
      Subject R&I in Biotechnology
      DG Research and Innovation
      Attending
      • Jean-Eric Paquet (Director-General)
    • Date 12 Mar 2019 Location Brussels
      Subject GMO import approvals and new breeding techniques
      Cabinet Cabinet of Commissioner Vytenis Andriukaitis
      Portfolio Health &amp; Food Safety
      Attending
      • Nathalie Chaze (Cabinet member)
      Other Lobbyists
    • Date 12 Oct 2018 Location Brussels, Belgium
      Subject Introductory meeting with the new SG
      Cabinet Cabinet of Commissioner Vytenis Andriukaitis
      Portfolio Health &amp; Food Safety
      Attending
      • Arunas Vinciunas (Cabinet member)
    • Date 15 Jun 2018 Location Brussels, Berl
      Subject HTA
      Cabinet Cabinet of Commissioner Vytenis Andriukaitis
      Portfolio Health &amp; Food Safety
      Attending
      • Annika Nowak (Cabinet member)
      • Vytenis Andriukaitis (Commissioner)
      Other Lobbyists
    • Date 18 May 2018 Location Brussels
      Subject SPC manufacturing waiver
      Cabinet Cabinet of Vice-President Günther Oettinger
      Portfolio Budget &amp; Human Resources
      Attending
      • Michael Hager (Cabinet member)
    • Date 25 Apr 2018 Location Brussels
      Subject Business discussion
      Cabinet Cabinet of Commissioner Phil Hogan
      Portfolio Agriculture &amp; Rural Development
      Attending
      • Tom Tynan (Cabinet member)
    • Date 10 Apr 2018 Location Brussels
      Subject IP regime generic manufacturers in the pharmaceutical industry
      Cabinet Cabinet of Commissioner Pierre Moscovici
      Portfolio Economic and Financial Affairs, Taxation and Customs
      Attending
      • Leila Fernandez-Stembridge (Cabinet member)
    • Date 23 Jan 2018 Location Brussels
      Subject Update of the Bioeconomy strategy
      Cabinet Cabinet of Commissioner Carlos Moedas
      Portfolio Research, Science and Innovation
      Attending
      • Robert Schröder (Cabinet member)
    • Date 11 Jan 2018 Location Brussels, Belgium
      Subject Discussion on future EuropaBio events
      Cabinet Cabinet of Commissioner Vytenis Andriukaitis
      Portfolio Health &amp; Food Safety
      Attending
      • Arunas Vinciunas (Cabinet member)
    • Date 29 Aug 2017 Location Brussels
      Subject GMO import authorization process including several dossiers pending Commission authorization (following recent appeal committee votes), EC proposal to change comitology rules , Debate around the legal status of New Plant Breeding Techniques including genome editing
      Cabinet Cabinet of Commissioner Phil Hogan
      Portfolio Agriculture &amp; Rural Development
      Attending
      • Dermot Ryan (Cabinet member)
    • Date 24 Aug 2017 Location Brussels
      Subject Introduction of the New Secretary General
      Cabinet Cabinet of Commissioner Carlos Moedas
      Portfolio Research, Science and Innovation
      Attending
      • Giulia Del Brenna (Cabinet member)
    • Date 13 Jul 2017 Location Brussels
      Subject Introductory meeting of EuropaBio's new Secretary General
      Cabinet Cabinet of Commissioner Vytenis Andriukaitis
      Portfolio Health &amp; Food Safety
      Attending
      • Arunas Vinciunas (Cabinet member)
    • Date 17 Nov 2016 Location Brussels
      Subject Roundtable on the future of the General Food Law Regulation
      Cabinet Cabinet of Commissioner Vytenis Andriukaitis
      Portfolio Health &amp; Food Safety
      Attending
      • Nathalie Chaze (Cabinet member)
      • Marco Valletta (Cabinet member)
      • Vytenis Andriukaitis (Commissioner)
      Other Lobbyists
    • Date 27 Jun 2016 Location Brussels
      Subject New breeding techniques, innovation in seeds
      Cabinet Cabinet of Commissioner Vytenis Andriukaitis
      Portfolio Health &amp; Food Safety
      Attending
      • Nathalie Chaze (Cabinet member)
      • Vytenis Andriukaitis (Commissioner)
      Other Lobbyists
    • Date 07 Dec 2015 Location Brussels
      Subject Health and food aspect of biotech
      DG Health and Food Safety
      Attending
      • Xavier Prats Monné (Director-General)
    • Date 21 Oct 2015 Location Brussels
      Subject current challenges for the biotech industry
      DG Internal Market, Industry, Entrepreneurship and SMEs
      Attending
      • Lowri Evans (Director-General)
    • Date 16 Jul 2015 Location Brussels, Belgium
      Subject Biotechnology Industry
      Cabinet Cabinet of Commissioner Elżbieta Bieńkowska
      Portfolio Internal Market, Industry, Entrepreneurship and SMEs
      Attending
      • Kaius Kristian Hedberg (Cabinet member)
    • Date 08 Jul 2015 Location Brussels
      Subject Digital Publishing
      DG Communications Networks, Content and Technology
      Attending
      • Robert Madelin (Director-General)
      Other Lobbyists
    • Date 08 Jul 2015 Location Brussels
      Subject Digital Publishing
      DG Communications Networks, Content and Technology
      Attending
      • Robert Madelin (Director-General)
      Other Lobbyists
    • Date 23 Jun 2015 Location Brussels
      Subject Participation of Commissioner at event
      Cabinet Cabinet of Commissioner Vytenis Andriukaitis
      Portfolio Health &amp; Food Safety
      Attending
      • Vytenis Andriukaitis (Commissioner)
      • Nathalie Chaze (Cabinet member)
    • Date 02 Mar 2015 Location Brussels
      Subject Healthcare (personalised medicine which will be a priority of the LU Presidency, Biosimilars, Advanced Therapy Medicinal Products (ATMPs), Health Technology Assessment (HTA) and GMO'S
      Cabinet Cabinet of Commissioner Vytenis Andriukaitis
      Portfolio Health &amp; Food Safety
      Attending
      • Nathalie Chaze (Cabinet member)
      • Vytenis Andriukaitis (Commissioner)
    • Date 17 Feb 2015 Location Brussels
      Subject Health and JCJ Goals
      DG Communications Networks, Content and Technology
      Attending
      • Robert Madelin (Director-General)
    • Date 17 Feb 2015 Location Brussels
      Subject Health and JCJ Goals
      DG Communications Networks, Content and Technology
      Attending
      • Robert Madelin (Director-General)
    • Date 12 Feb 2015 Location Brussels
      Subject Digital Single Market, Innovation
      DG Communications Networks, Content and Technology
      Attending
      • Robert Madelin (Director-General)
      Other Lobbyists
    • Date 12 Feb 2015 Location Brussels
      Subject Digital Single Market, Innovation
      DG Communications Networks, Content and Technology
      Attending
      • Robert Madelin (Director-General)
      Other Lobbyists
    • Date 03 Feb 2015 Location Brussels
      Subject Bioeconomy
      Cabinet Cabinet of Vice-President Jyrki Katainen
      Portfolio Jobs, Growth, Investment and Competitiveness
      Attending
      • Grzegorz Radziejewski (Cabinet member)
      • Jyrki Katainen (Vice-President)
    • Date 02 Feb 2015 Location Brussels
      Subject Meeting with the European Bioeconomy Alliance on the Bioeconomy Strategy
      Cabinet Cabinet of Commissioner Carlos Moedas
      Portfolio Research, Science and Innovation
      Attending
      • Carlos Moedas (Commissioner)
      Other Lobbyists
    • Date 21 Jan 2015 Location Brussels (BELGIUM)
      Subject GMO
      DG Health and Food Safety
      Attending
      • Ladislav Miko (acting Director-General)
    • Date 14 Jan 2015 Location Brussels
      Subject Bioindustries and biotechnology
      Cabinet Cabinet of Vice-President Jyrki Katainen
      Portfolio Jobs, Growth, Investment and Competitiveness
      Attending
      • Heidi Jern (Cabinet member)
    • Date 14 Jan 2015 Location Brussels, Belgium
      Subject Meeting with Introductory meeting w. Europabio to discuss the biotechnology industry in Europe (healthcare, agri-food and bioeconomy/industrial biotechnology field)
      Cabinet Cabinet of Commissioner Elżbieta Bieńkowska
      Portfolio Internal Market, Industry, Entrepreneurship and SMEs
      Attending
      • Rolf Carsten Bermig (Cabinet member)
    • Date 10 Dec 2014 Location Brussels
      Subject Biotechnology
      Cabinet Cabinet of Commissioner Phil Hogan
      Portfolio Agriculture &amp; Rural Development
      Attending
      • Shane Sutherland (Cabinet member)
    • Date 09 Dec 2014 Location Brussels
      Subject Preparation of Commissioner's participation to future Europabio event, personalised medicines; GMOs.
      Cabinet Cabinet of Commissioner Vytenis Andriukaitis
      Portfolio Health &amp; Food Safety
      Attending
      • Nathalie Chaze (Cabinet member)
    • Date 05 Dec 2014 Location B232 07/066
      Subject New transparency rules and pending GM authorisations
      DG Health and Food Safety
      Attending
      • Ladislav Miko (acting Director-General)
Download this datacard